SCHEMBL9355151

SCHEMBL9355151

O=C1CCCCCCC=CCCCCCC1

nearest known ligand 0.65

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
TRIM24 O15164 2/20 0.65
TRIM33 Q9UPN9 2/20 0.65
ALDH1A1 P00352 2/20 0.65
HDAC3 O15379 4/20 0.35
HDAC4 P56524 4/20 0.35
HDAC1 Q13547 4/20 0.35
HDAC7 Q8WUI4 4/20 0.35
HDAC2 Q92769 4/20 0.35
HDAC10 Q969S8 4/20 0.35
HDAC11 Q96DB2 4/20 0.35
HDAC8 Q9BY41 4/20 0.35
HDAC6 Q9UBN7 4/20 0.35
HDAC9 Q9UKV0 4/20 0.35
HDAC5 Q9UQL6 4/20 0.35
CXCR3 P49682 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Cyclohexanone SCHEMBL8679167 1.00 TRIM24 (0.65) TRIM24TRIM33ALDH1A1HDAC3HDAC4
SCHEMBL4903664 1.00 TRIM24 (0.65) TRIM24TRIM33ALDH1A1HDAC3HDAC4
SCHEMBL2196651 1.00 TRIM24 (0.65) TRIM24TRIM33ALDH1A1HDAC3HDAC4
SCHEMBL2197202 1.00 TRIM24 (0.65) TRIM24TRIM33ALDH1A1HDAC3HDAC4
SCHEMBL17629439 1.00 TRIM24 (0.65) TRIM24TRIM33ALDH1A1HDAC3HDAC4
SCHEMBL2193717 1.00 TRIM24 (0.65) TRIM24TRIM33ALDH1A1HDAC3HDAC4
SCHEMBL1472595 1.00 TRIM24 (0.65) TRIM24TRIM33ALDH1A1HDAC3HDAC4
SCHEMBL2197197 1.00 TRIM24 (0.65) TRIM24TRIM33ALDH1A1HDAC3HDAC4
SCHEMBL110906 1.00 TRIM24 (0.65) TRIM24TRIM33ALDH1A1HDAC3HDAC4
SCHEMBL16706906 1.00 TRIM24 (0.65) TRIM24TRIM33ALDH1A1HDAC3HDAC4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0025870-B1 CYCLOPENTADECEN-8-ONE-1, PROCESS FOR ITS PREPARATION, AND ITS USE AS ODORANT HAARMANN & REIMER GMBH (DE) 1983-03-02 EP claimed
EP-3359517-B1 METHOD FOR THE PURIFICATION OF CYCLOHEXADEC-8-EN-1-ON BASF SE (DE) 2019-09-25 EP disclosed
US-20180312458-A1 METHOD F0R THE PURIFICATION OF CYCLOHEXADEC-8-EN-1-ONE BASF SE (DE) 2018-11-01 US disclosed
US-20180290959-A1 USE OF NOVEL MIXTURES OF (E/Z) CYCLOPENTADECENONE ISOMERS, THE PRODUCTION AND USE THEREOF AS FLAVORING SUBSTANCE BASF SE (DE) 2018-10-11 US disclosed
WO-2017060440-A1 USE OF NOVEL MIXTURES OF (E/Z) CYCLOPENTADECENONE ISOMERS, THE PRODUCTION AND USE THEREOF AS FLAVORING SUBSTANCE BASF SE (DE) 2017-04-13 WO disclosed
WO-2017060437-A1 METHOD FOR THE PURIFICATION OF CYCLOHEXADEC-8-EN-1-ONE BASF SE (DE) 2017-04-13 WO disclosed
EP-3153493-A1 METHOD FOR THE PURIFICATION OF CYCLOHEXADEC-8-EN-1-ON BASF SE (DE) 2017-04-12 EP disclosed
EP-3153494-A1 USE OF NOVEL MIXTURES OF (E/Z) CYCLOPENTADECENON ISOMERS, THEIR PREPARATION AND THEIR USE AS AN AROMATIZING INGREDIENT BASF SE (DE) 2017-04-12 EP disclosed
EP-0291067-B1 Process for preparing cyclo-octa-amylose CONSORTIUM ELEKTROCHEM IND (DE) 1994-09-07 EP disclosed
US-4822874-A ENZYMATIC CLEAVAGE OF STARCH IN PRESENCE OF COMPLEXING AGENT CONSORTIUM FUR ELEKTROCHEMISCHE INDUSTRIE, GMBH (DE) 1989-04-18 US disclosed
EP-0216185-B1 16-Oxa-bicyclo[13.1.0]-hexadec-7-ene, process for its production and its use as a perfume Consortium für elektrochemische Industrie GmbH (DE) 1988-11-02 EP disclosed
US-4766107-A 16-Oxa-bicyclo-[13.1.0]-hexadec-7-ene and its application as a fragrance CONSORTIUM FUR ELEKTROCHEMISCHE INDUSTRIE GMBH (DE) 1988-08-23 US disclosed
EP-0216185-A1 16-Oxa-bicyclo[13.1.0]-hexadec-7-ene, process for its production and its use as a perfume Consortium für elektrochemische Industrie GmbH (DE) 1987-04-01 EP disclosed
EP-0025870-A1 Cyclopentadecen-8-one-1, process for its preparation, and its use as odorant HAARMANN & REIMER GMBH (DE) 1981-04-01 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180312458-A1 METHOD F0R THE PURIFICATION OF CYCLOHEXADEC-8-EN-1-ONE CNR1, C1R, FFAR1 TRIM24 3973/4885TRIM33 3935/4885ALDH1A1 289/4885
US-20180290959-A1 USE OF NOVEL MIXTURES OF (E/Z) CYCLOPENTADECENONE ISOMERS, THE PRODUCTION AND USE THEREOF AS FLAVORING SUBSTANCE OR51E2, OR10J3, ZDHHC20 TRIM24 3990/4885TRIM33 4786/4885ALDH1A1 193/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.